Table 2.
ROC analysis of CSF and Serum sFas/sFasL.
| AUC | 95% CI | |
|---|---|---|
| ANTI-NMDAR ENCEPHALITIS VS. NON-ANTI-NMDAR ENCEPHALITIS | ||
| CSF sFas | 0.859 | 0.745–0.972 |
| CSF sFasL | 0.806 | 0.681–0.930 |
| Serum sFas | 0.722 | 0.575–0.869 |
| Serum sFasL | 0.686 | 0.566–0.864 |
| ANTI-NMDAR ENCEPHALITIS VS. EOC | ||
| CSF sFas | 0.829 | 0.679–0.979 |
| CSF sFasL | 0.779 | 0.628–0.930 |
| Serum sFas | 0.644 | 0.456–0.832 |
| Serum sFasL | 0.619 | 0.425–0.812 |
| ANTI-NMDAR ENCEPHALITIS VS. PN | ||
| CSF sFas | 0.894 | 0.788–0.999 |
| CSF sFasL | 0.837 | 0.707–0.968 |
| Serum sFas | 0.814 | 0.670–0.959 |
| Serum sFasL | 0.830 | 0.695–0.964 |
CSF, cerebrospinal fluid; AUC, area under the curve; EOC, Encephalitis of other causes; PN, Peripheral neuropathy.